# Bristol-Myers Squibb Company (BMY) — Q3-2009 Earnings Results

**Report date:** 2009-10-22 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2009

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 1.01%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.52 | N/A | +1.56% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed a cautious optimism regarding future growth. They reiterated their focus on innovation and operational improvements.

**Key quotes:**

> Management highlighted ongoing commitment to pipeline development.

> They emphasized the importance of maintaining operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a slight beat on EPS, which indicates some positive performance in profitability. However, the stock reacted negatively, declining by 1.01%. This drop could reflect investor concerns about the lack of revenue data and absence of future guidance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2009_